NCT00090298View on ClinicalTrials.gov

Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,815

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Hypercholesterolemia
Interventions
DRUG

MK0653A, ezetimibe (+) simvastatin

DRUG

Comparator: Rosuvastatin

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00090298 - Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058) | Biotech Hunter | Biotech Hunter